Arama

EISSN 2980-1478

INDEXED IN WEB OF SCIENCE AND SCOPUS INDEXED IN PUBMED CENTRAL

Urology Research & Practice

PDF

HIGHLY CITED ARTICLES

Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study

By: Shah et al.

What do urologists need to know: Diagnosis, treatment, and follow-up during COVID-19 pandemic

By: Ho et al.

Thulium fiber laser: The new kid on the block

By: Schembri et al.

Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer

By: Danarto et al.

The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades

By: Gamage et al.

Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsy

By: Murray et al.

Problems and solutions of stent biofilm and encrustations: A review of literatüre

By: Khoddami et al.

First case of retroperitoneal hematoma in COVID-19

By: Scialpi et al.

Holmium laser enucleation of the prostate for the treatment of size-independent BPH: A single-center experience of 600 cases

By: Yalçın et al.

Transperineal prostate biopsy: The modern gold standard to prostate cancer diagnosis

By: By: Ortner et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 15 results

Ranking

Release Date Sort Sort Article Type

The risk factors for acute urinary retention in patients with benign prostatic hyperplasia

Hüseyin Cihan Demirel, Cevdet Serkan Gökkaya, Cüneyt Özden, Binhan Kağan Aktaş, Süleyman Bulut, Ali Memiş, Çetin Volkan Öztekin

(Urol Res Pract 2012; 38: 65-69) DOI: 10.5152/tud.2012.016

Abstract Full Text ( PDF) Related Articles

Deterioration of renal function in patients operated for lower urinary tract symptoms

Bülent Altunoluk, Ahmet Soylu, Ali Beytur, Haluk Söylemez, Can Baydinç

(Urol Res Pract 2011; 37: 147-152)

Abstract Full Text ( PDF) Related Articles

The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

Mehmet UMUL, Tekin Ahmet SEREL

(Urol Res Pract 2013; 39: 264-269) DOI: 10.5152/tud.2013.064

Abstract Full Text ( PDF) Related Articles

The risk factors for acute urinary retention in patients with benign prostatic hyperplasia

Deterioration of renal function in patients operated for lower urinary tract symptoms

The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

INITIAL SYMPTOM AS A LOWER URINARY TRACT IRRITATION FOR PENILE CANCER

The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia

Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study

Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group

The Modified Urdu version of International Prostate Symptom Score: A psychometric validation study

Where can urodynamic testing help assess male lower urinary tract symptoms?

Lower urinary tract dysfunction in common neurological diseases

Indications, techniques, and role of new minimally invasive benign prostate hyperplasia surgical options

Questionnaire survey assessing seasonal changes in lower urinary tract symptoms in men with benign prostate hyperplasia

Evolution of AquablationVR—From innovation to establishment

Management Modalities of Primary Bladder Neck Obstruction in Young Adult Men: A Systematic Review and Meta-analysis

Management Modalities of Primary Bladder Neck Obstruction in Young Adult Men: A Systematic Review and Meta-analysis